CRSP
CRISPR Therapeutics AG
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
CRISPR Therapeutics (CRSP) Stock: Buy, Sell, or Hold?
$45.15
-4.89 (-9.77%)
▼
5d:
-9.68%
30d:
-12.42%
90d:
-16.37%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 09, 2026
0d
Protect CRSP Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$48.75 – $53.48
Position: OVERSOLD
Forward P/E & Valuation
-12.3x
Next 12M consensus est.
Wall Street Target
$85.42
+89.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$44.99 / $55.82
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CRSP shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $45.15, which is considered oversold relative to its 30-day fair value range of $48.75 to $53.48.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $44.99. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: CRSP scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $85.42 (+89.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $44.99. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: CRSP scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $85.42 (+89.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$48.75 -
$53.48
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$48.75 -
$53.48
Current vs Trading Range
OVERSOLD
Support Level
$44.99
Resistance Level
$55.82
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding CRSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (19/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.8%)
- BULLISH: Trading 89.2% below Wall St target ($85.42)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-12.30
Wall Street Target
$85.42
(+89.2%)
Revenue Growth (YoY)
1325.1%
Share CRSP Analysis
Share this live CRSP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRSP)
Bearish
3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
CRISPR Therapeutics (CRSP) announced that members of its senior management team will present at the 2026 Jefferies Global Healthcare Conference. The Company is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases.
Key Retail Themes:
Company's focus on developing transformative gene-based medicines
Upcoming presentation at the Jefferies Global Healthcare Conference
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:13 AM ET
Data refreshes hourly during market hours. Next update: 6:13 AM
Data refreshes hourly during market hours. Next update: 6:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 55 HOLD |
|
RZLT
Rezolute Inc |
STRONG BUY
11 analysts |
$10 | 72 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRSP Research Pages
